Melanoma Antigen Preferentially Expressed In Tumors (PRAME) Antibody
195€ (20 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Melanoma Antigen Preferentially Expressed In Tumors (PRAME) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx004948
tested applications
ELISA, WB
Description
PRAME Antibody is a Rabbit Polyclonal antibody against PRAME. This gene encodes an antigen that is preferentially expressed in human melanomas and that is recognized by cytolytic T lymphocytes. It is not expressed in normal tissues, except testis. The encoded protein acts as a repressor of retinoic acid receptor, and likely confers a growth advantage to cancer cells via this function. Alternative splicing results in multiple transcript variants.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Melanoma Antigen Preferentially Expressed In Tumors (PRAME) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | ELISA: 1 µg/ml, WB: 1/500 - 1/2000. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified by affinity chromatography. |
| Size 1 | 20 µl |
| Size 2 | 100 µl |
| Size 3 | 2 × 100 µl |
| Form | Liquid |
| Tested Applications | ELISA, WB |
| Buffer | PBS, pH 7.3, containing 0.02% sodium azide, 50% glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P78395 |
| Gene ID | 23532 |
| NCBI Accession | NP_006106.1 |
| OMIM | 606021 |
| Background | Antibody anti-PRAME |
| Status | RUO |
| Note | Concentration: > 0.2 mg/ml - |
Descripción
Related Products
Human PRAME (Melanoma antigen preferentially expressed in tumors) ELISA Kit
Ver Producto
PRAME antibody
Functions as a transcriptional repressor, inhibiting the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG. Prevents retinoic acid-induced cell proliferation arrest, differentiation and apoptosis.
Ver Producto